National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 70691 [2016-24694]
Download as PDF
Federal Register / Vol. 81, No. 198 / Thursday, October 13, 2016 / Notices
diagnostic applications and can be
visualized through microscopy.
Potential Commercial Applications
• Imaging
• Therapeutics
Competitive Advantages
• Higher degree of functionalization for
carbon nanoparticles
Development Stage
• Early Stage
Inventors: Keir Neuman, Rolf
Swenson, Ganesh Shenoy,
Chandrasekhar Mushti (all of NHLBI).
Lhorne on DSK30JT082PROD with NOTICES
Dated: October 6, 2016.
Michael Shmilovich,
National Heart, Lung and Blood Institute,
Office of Technology Transfer and
Development, National Institutes of Health.
[FR Doc. 2016–24693 Filed 10–12–16; 8:45 am]
BILLING CODE 4140–01–P
Publications:
1. Mochalin, V. N.; Shenderova, O.; Ho, D.;
Gogotsi, Y., The Properties and
Applications of Nanodiamonds. Nature
Nanotechnology 2012, 7 (1), 11–23.
2. Huang, J.; Deming, C. P.; Song, Y.; Kang,
X.; Zhou, Z.-Y.; Chen, S., Chemical
Analysis of Surface Oxygenated Moieties
of Fluorescent Carbon Nanoparticles.
Nanoscale 2012, 4 (3), 1010–1015.
3. Nystrom, R. F.; Brown, W. G., Reduction
of Organic Compounds by Lithium
Aluminum Hydride. I. Aldehydes,
Ketones, Esters, Acid Chlorides and Acid
Anhydrides. Journal of the American
Chemical Society 1947, 69 (5), 1197–
1199.
4. Nystrom, R. F.; Brown, W. G., Reduction
of Organic Compounds by Lithium
Aluminum Hydride. Ii. Carboxylic
Acids. Journal of the American Chemical
Society 1947, 69 (10), 2548–2549.
5. Aller, E.; Brown, D. S.; Cox, G. G.; Miller,
D. J.; Moody, C. J. Diastereoselectivity in
the O–H Insertion Reactions of Rhodium
Carbenoids Derived from
Phenyldiazoacetates of Chiral Alcohols.
Preparation Of .Alpha.-Hydroxy And
.Alpha.-Alkoxy Esters. The Journal of
Organic Chemistry 1995, 60 (14), 4449–
4460.
6. Hoehnel, S; Lutolf, M.P., Capturing CellCell Interactions via SNAP-tag and CLIPtag Techology. Bioconjugate Chemistry
2015, 26, 1678–1686.
7. Moon, W. K.; Lin, Y.; O’Loughlin, T.; Tang,
Y.; Kim, D.-E.; Weissleder, R.; and Tung,
C.-H., Enhanced Tumor Detection Using
a Folate Receptor-Targeted Near-Infrared
Fluorochrome Conjugate. Bioconjugate
Chemistry 2003, 14, 539–545.
8. Fu, C. C.,Lee, H. Y., Chen, K. C., Lim, T.
S.,Wu, H. Y., Lin, P. K.,Wei, P. K., Tsao,
P. H., Chang, H. C., Fann, W.
Characterization and application of
single fluorescent nanodiamonds as
cellular biomarkers. Proceedings of the
National Academy of Sciences of the
United States of America, 2007, 104(3),
727–732.
9. Chang, B. M., Lin, H. H., Su, L. J., Lin, W.
D., Lin, R. J., Tzeng, Y. K, Lee, R. T., Lee,
Y. C., Yu, A. L., Chang, H. C., Highly
Fluorescent Nanodiamonds ProteinFunctionalized for Cell Labeling and
Targeting. Advanced Functional
Materials 23(46): 5737–5745.
VerDate Sep<11>2014
Intellectual Property: HHS Reference
No. E–207–2016/0.
• US Provisional Patent Application
No. 62/402,339 filed 30 September
2016.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov.
14:07 Oct 12, 2016
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence
Review Committee.
Date: November 3–4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
70691
October 5, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24694 Filed 10–12–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee meeting
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on October
18, 2016. The subject of the meeting will
be ‘‘How Reproducible Are People?
Understanding Health Histories Using
Medicare Claims Data.’’ The meeting is
open to the public.
DATES: The meeting will be held on
October 18, 2016; from 1:00 p.m. to 3:30
p.m. Individuals wanting to present oral
comments must notify the contact
person at least 10 days before the
meeting date.
ADDRESSES: The meeting will be held in
the Democracy 2 Building at 6707
Democracy Blvd., Bethesda, MD, in
Conference Room 7050.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, see the DMICC Web site,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
October 18, 2016 DMICC meeting will
focus on How Reproducible Are People?
Understanding Health Histories Using
Medicare Claims Data.
SUMMARY:
E:\FR\FM\13OCN1.SGM
13OCN1
Agencies
[Federal Register Volume 81, Number 198 (Thursday, October 13, 2016)]
[Notices]
[Page 70691]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24694]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Mentored Transition to Independence Review Committee.
Date: November 3-4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD
20892, 301-435-0287, Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
October 5, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-24694 Filed 10-12-16; 8:45 am]
BILLING CODE 4140-01-P